Clinical Trials
2 trialsNCT01553071 2022-03-31
Phase I Trial of IV Fenretinide (4-HPR) Plus IV Safingol for Patients With Relapsed Malignancies
South Plains Oncology Consortium
Phase 1 Terminated
NCT01479192 2018-11-07
Fenretinide in Healthy Young Women at Genetic and Familial Risk
European Institute of Oncology
Phase 3 Terminated